The use of non-TNF targeted biologics in Behçet’s Disease: Real-life data from the International AIDA Network Behçet’s Disease Registry

Biologics targeting IL-1, IL-6, IL-17, and IL-12/23 pathways may offer therapeutic alternatives in BD patients unresponsive to TNF-α inhibitors. The treatment efficacy varies across phenotypes, highlighting the need for individualized treatment decisions.

Authors

Institutions

Publication Details

Journal
Lara D. Veeken
Published
2026-02-11
DOI
https://doi.org/10.1093/rheumatology/keag086
Primary Topic
Ocular Diseases and Behçet’s Syndrome
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The use of non-TNF targeted biologics in Behçet’s Disease: Real-life data from the International AIDA Network Behçet’s Disease Registry

Stefano Gentileschi, Gaafar Ragab, G. Lopalco, F. Iannone et al.
Lara D. Veeken
Ocular Diseases and Behçet’s Syndrome
article

The use of non-TNF targeted biologics in Behçet’s Disease: Real-life data from the International AIDA Network Behçet’s Disease Registry

Stefano Gentileschi, Gaafar Ragab, G. Lopalco, F. Iannone, Fatma Alıbaz-Öner, C. Fabiani, Valeria Caggiano, Antonio Vitale, Ombretta Viapiana, Piero Ruscitti, J. Sota, Francesco Carubbi, M. Frassi, Alessandro Conforti, Gizem Sevik, Giacomo Emmi, Matteo Piga, Ibrahim Almaghlouth, Abdurrahman Tufan, Francesco Ciccia, Andrés González-García, Roberto Giacomelli, Haner Direskeneli, Antonella Insalaco, Rosaria Talarico, Luca Cantarini
article en

Abstract

Biologics targeting IL-1, IL-6, IL-17, and IL-12/23 pathways may offer therapeutic alternatives in BD patients unresponsive to TNF-α inhibitors. The treatment efficacy varies across phenotypes, highlighting the need for individualized treatment decisions.

Lara D. Veeken
University of Siena (IT), University of Pisa (IT), University of Trieste (IT), Cairo University (EG), Università Campus Bio-Medico (IT), University of Cagliari (IT), University of L'Aquila (IT), Monash Medical Centre (AU), King Saud University (SA), Rite Aid (United States) (US), Azienda Ospedaliera Universitaria Integrata Verona (IT), Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari (IT), Ospedale di Cattinara (IT), San Salvatore Hospital (IT), Autoimmune Technologies (United States) (US), Bambino Gesù Children's Hospital (IT), University of Campania "Luigi Vanvitelli" (IT), Azienda Ospedaliera Universitaria Senese (IT), ERN GUARD-Heart (NL), Campus Bio Medico University Hospital (IT), Fondazione Cassa di Risparmio Civitavecchia (IT), The Memory Clinic (US), Center for Rheumatology (US), Hospital Universitario Ramón y Cajal (ES), October 6 University (EG), Azienda Ospedaliera Universitaria Pisana (IT), University of Bari Aldo Moro (IT), Marmara University (TR), University of Brescia (IT), Gazi University (TR)
Partnerships for the goals
Openalex Percentile: Top 51%
Ocular Diseases and Behçet’s Syndrome
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.